5 completed, 1 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 5, Terminated 1 |
Follow Cytomegalovirus Infection: new trials by email Literature Review of Cytomegalovirus Infection trials Research Report on Cytomegalovirus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A Everolimus, mycophenolic acid - Transplantation Infection, Cytomegalovirus Infection | Phase 4 | Completed | University Hospital, Bordeaux | 186 | 2014-05-02 | 2026-07-27 |
| CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") Valganciclovir - Cytomegalovirus Infection | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 205 | 2012-10-29 | 2021-08-26 |
| Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate Thymoglobulin, Everolimus, Basiliximabe - Cytomegalovirus Infection, Renal Transplant Failure | Phase 4 | Completed | Hospital do Rim e Hipertensão | 300 | 2011-05-01 | 2015-03-23 |
| In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir Valacyclovir (ZELITREX), Placebo - Viral Disease, Cytomegalovirus Infection | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 6 | 2009-09-01 | 2012-10-15 |
| Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients Single arm (ganciclovir and valganciclovir) - Cytomegalovirus Infection | Phase 4 | Completed | Salvador Gil-Vernet | 21 | 2004-03-01 | 2011-09-21 |
| Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients Ganciclovir - DNA Virus Infection, Herpesviridae Infections | Phase 4 | Completed | Lower Saxony Center for Nephrology | 150 | 2000-08-01 | 2006-09-13 |
Cytomegalovirus Infections (6) · Multiple Acyl Coenzyme A Dehydrogenase Deficiency (3) · DNA Virus Infections (1) · Disease (1) · Herpesviridae Infections (1) · Rejection, Psychology (1) · Virus Diseases (1)
Infections (6) · DNA Virus Infections (5) · Herpesviridae Infections (5) · Virus Diseases (5) · Amino Acid Metabolism, Inborn Errors (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Metabolic Diseases (3) · Metabolism, Inborn Errors (3) · Mitochondrial Diseases (3) · Nutritional and Metabolic Diseases (3) · Behavior (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Social Behavior (1)
Everolimus (2) · Ganciclovir (2) · Mycophenolic Acid (2) · Valganciclovir (2) · Tacrolimus (1) · Valacyclovir (1) · thymoglobulin (1)
Assistance Publique - Hôpitaux de Paris (1) · Hospital do Rim e Hipertensão (1) · Lower Saxony Center for Nephrology (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Salvador Gil-Vernet (1) · University Hospital, Bordeaux (1)
France (2) · Brazil (1) · Spain (1) · United States (1)
Volker Kliem, MD (1)
PMID 38700045, PMID 39807668, PMID 19738014, PMID 25988935, PMID 32286644, PMID 32726431, PMID 33988338, PMID 34725108, PMID 34990047